any peptides and proteins have a propensity to misfold and aggregate into amyloid fibrils, which consist of extended cross-β sheets with hydrogen bonds along the fibril axis 1 . For pharmaceutical peptides, this aggregation propensity presents a major challenge in drug formulation 2 , because the efficacy of peptide drugs requires both high bioavailability and physical stability. Glucagon and insulin are peptide hormones responsible for blood sugar homeostasis and are used in the management of blood sugar levels in patients with diabetes. Insulin lowers the blood glucose level by increasing the tissue uptake of glucose and is stable at room temperature for many weeks in its standard solution formulation 3 . In contrast, glucagon raises the blood glucose level and treats severe hypoglycemia 4 . However, at the pharmaceutical concentration of ~1 mg ml −1 , glucagon is insoluble at neutral pH and becomes soluble at basic pH (greater than 9) but undergoes chemical degradation 5 .
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At an acidic pH of less than 3, glucagon is both soluble and chemically stable, but fibrillizes within hours 6 . Therefore, the most common formulation of glucagon approved by the US Food and Drug Administration consists of a lyophilized peptide hydrochloride powder that is reconstituted into an acidic solution immediately before administration. Elucidating the molecular structure of low-pH glucagon fibrils is thus crucial for achieving stable solution-state formulations of glucagon to enable the implementation of dual insulin/ glucagon pumps as an 'artificial pancreas' for patients with diabetes.
X-ray diffraction, Fourier-transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM) and atomic force microscopy (AFM) have been used to characterize the hydrogen bonding, widths and morphologies of glucagon fibrils prepared under a variety of conditions [7] [8] [9] [10] [11] [12] . However, these studies have given inconclusive results and no atomic-level structural information on any of the fibril polymorphs. Most known amyloid fibril structures formed by proteins that are implicated in neurodegenerative diseases show parallel-in-register cross-β sheets, which often coexist with dynamically disordered domains [13] [14] [15] [16] . Only microcrystals of short peptide fragments have been observed to form thermodynamically stable, antiparallel and fully rigid structures 17 . This observation has led to the hypothesis that the parallel-in-register cross-β motif may be the thermodynamically favored structure for all full-length amyloid fibrils because it maximizes favorable hydrophobic interactions as well as polar interactions along the fibril axis 18 . In addition to the predominance of parallel-in-register β-sheet structures, solid-state NMR and TEM data of amyloid-β peptides in Alzheimer's disease and other neurodegenerative amyloid fibrils have shown that each ultrastructural fibril morphology corresponds to a single molecular conformation with a single mode of intermolecular assembly [19] [20] [21] . We have now determined the atomic structure of glucagon fibrils formed under pharmaceutically relevant concentrations and pH. Using solid-state NMR spectroscopy and 13 C-and 15 N-labeled peptides, we measured conformation-dependent 13 C and 15 N chemical shifts of the full-length peptide and numerous intramolecular and intermolecular distance restraints, thus determining the threedimensional (3D) structure and intermolecular packing of the glucagon fibrils. Strikingly, glucagon fibrillizes into a pair of antiparallel β-sheets that harbor two distinct molecular conformations alternating along the fibril axis. To our knowledge, this structural motif has not been observed in other amyloid fibrils to date and demonstrates a unique case of molecular structural polymorphism within a single ultrastructural morphology. Moreover, this structure suggests future strategies for developing glucagon analogs that resist fibril formation.
2 under quiescent conditions. Two types of 13 C-and 15 N-labeled peptides were synthesized (Table 1) : samples containing scattered labeled residues allow the measurement of well-resolved spectra with unambiguous long-range inter-residue distance restraints, whereas samples with consecutively labeled residues allow sequence-specific resonance assignment. Fibrils were formed at ambient temperature over the course of 7 d with highly reproducible morphology and kinetics. Within 12 h, the aggregates had already taken on a predominantly β-strand conformation, as evidenced by circular dichroism (CD) spectra (Fig. 1a) . Dynamic light scattering (DLS) data showed a progressive increase in the average particle size and polydispersity of particle sizes over a week (Fig. 1b) . At the end of 7 d, mature fibrils measured ~1 μm in length, 6-10 nm in width ( Fig. 1c) and were predominantly straight 7 . Consistent with the homogeneous fibril morphology, magicangle-spinning (MAS) solid-state NMR spectra of the fibrils show narrow 13 C linewidths of 0.6-0.9 ppm and 15 N linewidths of 1.0-1.3 ppm (Supplementary Figs. 1-3 ), indicating structural homogeneity at the molecular level. Unexpectedly, two sets of equal-intensity peaks are observed for the entire peptide (Fig. 2a-c) , indicating the coexistence of two distinct molecular conformations at a 1:1 ratio. The average chemical shift difference per residue exceeds 0.5 ppm from Q3 to Y13 and from F22 to T29 while being smaller for the central residues (Fig. 2e) .
Glucagon forms a rigid β-strand spanning a length of ~10 nm. Two-dimensional (2D) and 3D 15 N- 13 C correlation spectra (Fig.  2b,d and Supplementary Fig. 4) Table 2 ). The lack of (ϕ, ψ) angle variations is surprising because most β-strands in known amyloid fibril structures and in β-barrel membrane proteins contain fewer than 10 residues, spanning ~3 nm 20, 22 , whereas a straight β-strand formed by a 29-residue peptide would span an extraordinary length of ~10 nm. Glucagon assembles into antiparallel hydrogen-bonded β-sheets. To verify whether glucagon indeed forms a continuous β-strand and to determine how multiple peptide chains associate with each other in the fibril, we measured long-range 2D 13 C-13 C correlation spectra. Using 13 C spin diffusion (SD) with 250 ms and 500 ms mixing, protonassisted recoupling (PAR) 23 with 12 ms mixing, and proton-enhanced rotor-echo short pulse irradiation cross polarization ( PERSPIRATION CP) 24 with 15 ms mixing, we detected many correlation peaks between residues at the two ends of the peptide, such as S8-V23, T5-M27 and H1-T29 (Fig. 3a-c and Supplementary Fig. 6a-d) . To distinguish whether these long-range correlations result from intramolecular contacts due to a strand-turn-strand fold 20 or intermolecular contacts due to antiparallel packing of multiple β-strands, we mixed labeled peptide with unlabeled peptide in a 1:3 ratio before fibrillization and measured their spectra. All long-range cross peak intensities decreased by approximately the dilution factor of 4 ( Fig. 3a and Supplementary Fig. 7 ), proving that these long-range correlations are intermolecular in origin. Moreover, for each pair of correlated residues, only two, not four, cross peaks are observed, indicating that the correlation is exclusively intermolecular, between conformer I and conformer II, and not a combination of intermolecular (I-II) and intramolecular (I-I and II-II), thus ruling out a strand-turn-strand fold. The sum of the residue numbers for these long-range correlations ranges from 30 to 32 (Fig. 3e) , indicating that multiple chains associate with each other with a well-defined antiparallel registry.
So far, all known high-resolution structures of naturally occurring amyloid fibrils have parallel-in-register hydrogen bonds along the fibril axis [13] [14] [15] 20, 25 , with the exception of the D23N mutant of amyloid-β , which forms either a thermodynamically favored parallel-in-register cross-β fibril or a kinetically favored antiparallel cross-β fibril 26 . The surprising antiparallel arrangement of glucagon β-strands could in principle occur either via backbone N-H···O=C hydrogen bonds or via side chain packing. To determine which scenario is correct, we measured . For hydrogen-bonded antiparallel β-sheets, intermolecular Hα-Hα distances are much shorter than their intramolecular counterparts, so strong Cα-Cα cross peaks are expected for antiparallel hydrogen-bonded β-sheets but not for parallel β-sheets. Using a short 1 H spin diffusion time of 200 μs, we observed many strong Cα-Cα cross peaks such as S8-V23 and T5-L26 in the CHHC spectra ( Fig. 3d and Supplementary Fig. 6e , f), indicating that glucagon assembles into antiparallel hydrogenbonded β-sheets.
The two conformers have different water-exposed surfaces.
What is the origin of the dual molecular conformations when the fibril morphology is homogeneous? To answer this question, we measured water-edited 2D 13 C- 13 C correlation spectra ( Fig. 3f and Supplementary Fig. 8 ) to detect well-hydrated residues 28, 29 . Water T7   II   T5   II   T5   II   T7   II   S11   II   S8   II   T7   II   V23   II   V23   II   A19   II   F6   II   Y10   II   Q20   II   Q24   II   T7   I   T5   I   T5   I   T7   I   S11   I   T7   I   T5   I   V23   I   V23   I   A19   I   F6   I   Y10   I   F22   I   S8   I   D9   I   Q24   I   D21   I T7   I&II   Y10   I&II   Q24   I&II   Q20   I&II   V23   I   A19   I   S8   I   T5   I   F6   I   F22   I   D9   I   D21   I   S11   I   D9   II   A19   II   S8   II   V23   II   T5   II   F22   II   S11   II   F6   II   D21   II . Both mechanisms lead to higher intensities for the water-exposed residues compared to residues sequestered in a dry interior. In a well-ordered β-sheet, the side chains of two sequential residues point in opposite directions; thus odd-numbered side chains should face one side of the β-sheet plane while even-numbered side chains should face the other side. Interestingly, the water-transferred cross peak intensities of odd-numbered residues such as T5, T7 and A19 are significantly higher in conformer II than in conformer I, while the water-transferred intensities of evennumbered residues such as S8 and V28 are higher in conformer I than in conformer II. Therefore, conformer I and conformer II have different wet and dry interfaces: conformer I packs odd-numbered residues at the dry steric-zipper interface whereas conformer II uses even-numbered residues to form the steric zipper.
Both conformers form homodimers in the fibril cross section. We further compared the cross peak intensities of diluted and undiluted peptides ( Supplementary Fig. 7 ). Dilution decreased the intensities of intraresidue cross peaks such as T5 I/II Cβ-Cγ 2 and Cβ-Cα relative to the diagonal Cβ peak by about 50%, indicating that some of the cross peak intensities result from intermolecular contact between T5 side chains in two monomers. Sequential cross peaks such as T5 I/II Cβ-F6 I/II Cα also decreased by ~50%, indicating that these sequential cross peaks also contain both intramolecular and intermolecular contributions. Furthermore, some of the long-range correlations manifest only one of the two I-II combinations, indicating asymmetry between the two conformers. II cross peaks are detected (Fig. 3a) , indicating that the M27 side chain is in T5   II   T5   I   T7   I   T7   II   T7   II   T7   I   S11   I   S11   II   S8   I   S8   II   T5   I   T5 C SD spectra of sample 3 with or without dilution. M27-T5 and M27-F6 cross peaks are observed, whose intensities decrease significantly on dilution of the labeled peptide with unlabeled peptide, supporting antiparallel packing of conformers I and II. b, 500 ms 13 C SD spectra of sample 9c. Y13-R18 correlations indicate cation-π interaction. c, 500 ms 13 C SD spectra of sample 2 show H1-T29 cross peaks, indicating that the two termini of the peptide come into close proximity. d, 200 μs CHHC spectrum of sample 1. Strong V23-S8 Cα-Cα cross peaks indicate that the antiparallel packing is along the hydrogen-bonded fibril axis. e, Summary of measured inter-residue correlations. Conformer I-I correlations are shown below the diagonal, whereas conformer II-II correlations are shown above the diagonal. These sequential contacts contain both intramolecular and intermolecular contributions and are shown as open squares. The unambiguously intermolecular conformer I-conformer II contacts are shown as black squares, with the x axis indicating conformer I and the y axis indicating conformer II. f, Full and water-edited 2D spectra of sample 8c. Residues T5, T7 and S11 are well-hydrated in conformer II but dehydrated in conformer I, indicating that the water-accessible surfaces differ between the two conformers. g, Intensity ratios between the water-edited spectra (S) and full spectra (S 0 ), showing relative water accessibility of the side chains. Even-numbered residues are more hydrated (high S/S 0 values) in conformer I, whereas odd-numbered residues are more hydrated in conformer II. h, Schematic of the glucagon β-strand packing. The fibrils contain two distinct β-strands that hydrogen bond in antiparallel along the fibril axis. The two strands in each homodimer cross section have C 2 symmetry around an axis parallel to the peptide backbone.
close proximity to T5 and other residues in conformer I but extends into water in conformer II. Finally, the two V23 Cγ chemical shifts are split by 1.4 ppm in conformer I but are averaged to a single peak in conformer II (Fig. 2a and Supplementary Fig. 7a ), indicating that the V23 side chain is stabilized in conformer I by hydrophobic interactions with V23 across the homodimer interface, but is waterexposed and undergoes torsional fluctuations in conformer II.
These water accessibility, dilution and asymmetric side chain structural data together indicate that the two β-strand conformations in the glucagon fibril are distinguished by interdigitation of alternate side chains at the steric-zipper interfaces ( Fig. 3h and Supplementary Fig. 9a ) 17 . In conformer I, odd-numbered side chains, such as Y13 and W25, form the steric zipper whereas in conformer II even-numbered side chains, such as F6, Y10 and L26, form the dry interface. Within each cross section normal to the fibril axis, the β-strands align in parallel with C 2 symmetry about an axis parallel to both peptide backbones. The basic structural unit of the low-pH glucagon fibril is, therefore, a dimer-of-dimers that contains antiparallel backbone hydrogen bonding and parallel steric zippers with symmetry-breaking side chain conformations in alternating layers. In addition to favorable I-I and II-II homomeric interactions, there are favorable side chain interactions in the heteromeric interface, further stabilizing the assembly. This β-sheet assembly corresponds to the class-8 steric zipper that has been observed in microcrystals of small peptides 17 .
Glucagon fibril structure reveals stabilizing interactions. We calculated the structure of the low-pH glucagon fibrils using 350 intramolecular correlations (Supplementary Fig. 9d ), 285 intermolecular correlations (Supplementary Fig. 9e ) and 54 (φ, ψ) torsion angles predicted from chemical shifts. The resulting structural ensemble, consisting of the ten lowest-energy structures, (Fig. 4a,b) shows a pairwise backbone root mean squared deviation (r.m.s.d.) of 0.80 Å and a pairwise heavy-atom r.m.s.d. of 1.67 Å ( Table 2 ).
The structure shows many favorable side chain interactions such as a tetrameric 'aromatic box' at F6-W25, polar interactions at Q3-N28, T7-Q24, S11-Q20 and D15-S16, cation-π interactions at Y13-R18 and steric complementarity at M27-G4 (Fig. 4c,d ). Although the two R18
II side chains at the homodimer interface are expected to cause unfavorable electrostatic repulsion, this interaction is mitigated by the favorable heteromeric Y13 I -R18
II cation-π interaction. It is known that cation-π interactions contribute 0.5-2.5 kcal mol −1 to protein stability 33 , whereas aromatic π-stacking interactions provide 0.5-1.5 kcal mol −1 of stabilization 34, 35 . Polar interactions such as those involving Asn side chains in hydrophobic environments contribute 0.5-2.0 kcal mol −1 of stability 36, 37 , whereas each hydrogen bond in β-sheet backbones contributes 1-2 kcal mol −1 of stability 38 . These interactions thus provide considerable stability to the dimer-of-dimer β-sheet structure of the glucagon fibril. The homodimer in the fibril cross section has a thickness of ~2 nm, consistent with the average height of 1.97 ± 0.22 nm obtained from AFM data (Fig. 1d,e) . Mass-per-length (MPL) data ( Supplementary  Fig. 10 ) show a broad maximum centered at 40.1 kDa nm −1 , which corresponds to ~6 peptides, suggesting that three dimers associate in the mature fibril as the predominant structure under the experimental conditions used for scanning transmission electron microscopy (STEM). The ~10 nm length of each strand and the ~6 nm thickness of three associated dimers are also consistent with the fibril widths of 6-10 nm observed in negative-stain TEM images (Fig. 1c) . Water   M27  W25 V23 D21  A19  R17  D15  Y13  S11  D9  T7  T5  T29  Q3   N28  Q3   N28-Q3  Q20-S11  S8-V23  G4- Each conformer self-associates in parallel, exhibiting C 2 symmetry in the cross section normal to the fibril axis. Conformer I packs odd-numbered residues at the steric-zipper interface, whereas conformer II packs even-numbered residues at the steric-zipper interface. Hydrophobic side chains are colored white, polar residues are green, and positively charged residues are red. d, Enlarged views of F6-W25, Y13-R18 and Q3-N28 side chain packing, which stabilize the fibril structure. This antiparallel fibril structure contrasts with the glucagon structures in solution and when bound to its receptor. e, The micelle-bound glucagon is mostly disordered (PDB 1KX6) 43, 44 . f, The crystal structure of glucagon (PDB 1GCN) is predominantly an α-helical trimer, which may be the precursor to the β-sheet fibril. g, When bound to its G-protein coupled receptor in the lipid membrane, glucagon is fully α-helical 45 (PDB 5YQZ) and has many stabilizing interactions with the receptor.
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Discussion
To our knowledge, the low-pH glucagon fibril structure we describe here is unique among the amyloid fibril structures described to date by having two molecular conformations integrated within a single ultrastructural fibril morphology 39 , thermodynamically favored antiparallel hydrogen bonding and the involvement of the fulllength peptide in hydrogen bonding. The latter makes the glucagon β-strand the longest known among all peptides and proteins. In comparison, most neurodegenerative amyloid fibrils consist of parallel-in-register cross-β structures with one predominant molecular conformation and with significant numbers of disordered residues outside the β-sheet core 13, 16, 20, 40, 41 . The molecular conformational polymorphism of glucagon represents a different structural principle of amyloid assembly and may be present in other amyloid fibrils as more atomic-resolution structures become available.
Due to the involvement of the entire peptide in cross-β hydrogen bonding, the glucagon fibril has a relatively uniform width of ~10 nm. The side chain interfaces for the three dimers are also highly uniform, consistent with X-ray fiber diffraction data showing unusual periodicity in the equatorial plane 7 . The extraordinary length of the β-strand suggests that the peptide may zip up into fibrils from the two ends, promoted by favorable aromatic, hydrophobic and polar interactions along the way. Indeed, alanine scanning mutagenesis showed that fibrillization is slowed 3-10-fold by mutations at F6, V23 or M27, indicating the importance of the intermolecular interactions at these residues 42 . Glucagon is intrinsically disordered at low physiological concentrations (Fig. 4e) 43,44 before binding to its G-protein coupled receptor and acquiring an α-helical structure (Fig. 4g ) 45 . At moderately higher concentrations glucagon forms α-helical trimers 46 ( Fig. 4f) , which are likely to be the species responsible for initiating fibril growth 47, 48 . What gives glucagon the ability to convert among these multiple conformations, especially into a stable fibril with an unprecedented β-strand length? The structure of the fibril suggests that this conformational plasticity may result from the balance and complementarity between many types of residues: the peptide contains 11 polar residues (Ser, Thr, Gln and Asn), three acidic aspartate residues, four basic residues (His, Lys and Arg), five aromatic residues (Phe, Trp and Tyr) and five hydrophobic residues (Ala, Leu, Met and Val). The equally spaced D9, D15 and D21 are neutralized at pH 2, thus promoting steric-zipper formation in conformer I (Fig. 4c) , whereas at physiological pH the anionic D9 and D15 are stabilized by cationic Arg residues in the receptor 45 . F6 and W25 form essential interactions with Y145 of helix I and W36 of extracellular loop 1 of the receptor, respectively, but are also ideally positioned to interact with each other to form the aromatic box in its fibrillar structure (Fig. 4d) . Thus, the glucagon sequence encodes the ability to form a diverse set of 3D structures. This is also manifested by the fact that glucagon can produce different fibril morphologies under different concentrations, pH, temperature and mechanical conditions 10, 11 . At the pharmaceutical concentration of ~1 mg ml −1 , in addition to the straight fibrils studied here, a twisted fibril morphology also exists 49 and becomes predominant below 0.25 mg ml −1 . The fibril structure determined here is the more important form because its disruption should allow even higher concentrations of the peptide to be formulated in solution for potential applications in dual insulin/glucagon pumps.
Determination of the low-pH glucagon fibril structure opens the path for the rational design of glucagon analogs that resist fibril formation and increase the therapeutic efficacy. For example, previous mutagenesis studies found the F6A mutation to increase the lag time of fibril formation sevenfold 42 . The current structure suggests that this inhibition is due to the destabilizing effect of removing the aromatic interaction between F6 and W25. The activity-retaining mutation of Q3 to acetylated 2,4-diaminobutryic acid increased the solution stability 50 , likely because of the disruption of the favorable polar interactions between Q3 and N28. Future studies should aim to identify mutations that not only destabilize the dimer-of-dimer β-sheet structure but also prevent the adoption of alternative fibril structures, while at the same time retaining the receptor-binding activity of the native peptide to treat hypoglycemia.
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Methods
Preparation of isotopically labeled glucagon fibrils. All peptides were purchased from Biopeptek Pharmaceuticals and were >95% pure based on HPLC. Lyophilized peptide was dissolved in deionized water that was adjusted to pH 2 with HCl to produce a 13 mg ml −1 stock solution. The solution was briefly vortexed and when cloudy was subjected to bath sonication for less than a minute. The stock solution was filtered through a 0.2 µm syringe filter; the exact concentration after filtration was measured by UV spectroscopy at 280 nm using a molar extinction coefficient of 8,250
. This filtered stock solution was diluted to a final peptide concentration of 8 mg ml −1 and was incubated without shaking in Eppendorf tubes for 7 d at 21 °C. Solutions of 13 C-and 15 N-labeled peptide were fibrillized after seeding with a 30-45 μl aliquot from a previously formed unlabeled glucagon fibril to a final 'seed' concentration of 5% (600-900 μl).
Negative-stain transmission electron microscopy. Negative-stain TEM images of the pH 2 glucagon fibrils were measured using an FEI Tecnai Spirit Bio-Twin transmission electron microscope with an acceleration voltage of 120 kV. A 5 μl aliquot of the fibril solution was diluted 40-fold with water and mixed thoroughly, and 5 µl of this diluted solution was deposited onto the surface of a 200-mesh carbon-coated copper grid (Electron Microscopy Sciences). After 1 min, excess liquid was blotted off using filter paper and the grid was rinsed briefly with 5 µl of water. The rinse water was wicked away with filter paper and 5 µl of 1% uranyl acetate was added to the grid as a negative stain to enhance contrast. After 1 min, excess stain was blotted off and the grid was imaged immediately. Fibril width measurements were carried out using the program ImageJ.
Atomic force microscopy. AFM images were obtained using a Cypher ES AFM (Asylum Research) operating in alternate contact (tapping) mode with goldcoated ArrowUHF cantilevers. The cantilevers were driven at free air resonance (~1.2 MHz) via blueDrive photothermal excitation with the amplitude set point optimized to maintain net repulsive tip-sample interactions during the scan. A fibril stock solution (8 mg ml
) of 1-5 µl was deposited onto freshly cleaved mica (Ted Pella, Inc.), blotted with filter paper after ~30 s of incubation and allowed to air dry before imaging. Samples were scanned at 512 × 512 pixel resolution at 4.88 Hz in air at ambient temperature. A first-order X-Y plane fit was applied to the images to remove sample tilt. Circular dichroism. The secondary structure content of glucagon was analyzed using a JASCO J-1500 CD spectrophotometer and a 0.1-mm quartz cell. Ellipticity was measured on the pH 2 8 mg ml −1 peptide solution between 200 and 260 nm every hour for the first 24 h, followed by discrete time points at day 3 and day 7. The raw data were converted to mean residue ellipticity using the equation [θ] = θ obs /10(lcr), where θ obs is the measured ellipticity (mdeg), l is the path length (0.1 mm), c is the peptide concentration (M) and r is the number of residues in the peptide (29 for glucagon).
Dynamic light scattering. DLS measurements were obtained on a Zetasizer Nano ZS instrument (Malvern Panalytical) using a reduced-volume plastic cuvette. An 8 mg ml −1 peptide solution at pH 2 was prepared as above. At time points of 0, 1, 3 and 7 d, 100 µl of the solution was transferred to the cuvette and measured with an acquisition time of 10 s. The number of acquisitions per measurement (~15) was determined by the instrument and not manually controlled. Representative autocorrelation functions of the scattered light intensities were plotted and normalized in GraphPad Prism to show particle size and polydispersity trends.
MPL measurement by scanning transmission electron microscopy. To determine the number of cross-β sheets in the fibril, we measured the MPL using STEM. Images were collected using an FEI TALOS microscope equipped with a field emission gun operating with an extraction voltage of 4.5 kV and an acceleration voltage of 200 kV. Microtubules formed by porcine brain tubulin (Cytoskeleton, Inc.) were used as a standard to calibrate the mass density in the images 51 . Tubulin is composed of a heterodimer of 55 kDa proteins 52 ; each micron of microtubule contains 1,650 heterodimers, thus giving an MPL of 55 × 2 × 1,650/1,000 = 181.5 kDa nm −1 . Microtubule solution was prepared following the protocol provided by Cytoskeleton, Inc. A tubulin buffer was prepared by resuspending lyophilized tubulin buffer powder in deionized water to give a pH 7 solution (16 mM PIPES, 0.4 mM MgCl 2 , 0.1 mM EGTA). Then 99.1% pure lyophilized paclitaxel powder, which stabilizes microtubules, was resuspended in anhydrous dimethyl sulfoxide to give a 2 mM stock solution. About 100 μl of the paclitaxel solution was mixed with 10 ml of tubulin buffer, giving a resuspension buffer that was added to lyophilized microtubule powder containing 95% tubulin to a final concentration of 1 mg ml
Carbon-coated 200-mesh copper grids (CF200-Cu, Electron Microscopy Sciences, Inc.) were glow-discharged using a plasma cleaner (PDC-32G, Harrica Plasma, Inc.). About 4 μl of the microtubule solution was applied onto the grid, allowed to adsorb for 1 min and then blotted off. The grid was washed once with ~4 μl of deionized water, blotted immediately and dried for 5 min. To stain the microtubules (Supplementary Fig. 10a ), 4 μl of a 1% phosphotungstic acid solution (pH 7) was applied to the grid, allowed to absorb for 30 s and then blotted off. These stained samples were examined in the bright-field mode to verify the presence of the microtubules.
To measure the MPL of glucagon fibrils, 3 μl of glucagon fibril solution (8 mg ml −1 ) was applied onto the grid that contains unstained microtubules, incubated for 30 s, blotted off and washed with deionized water three times. The grids were first imaged in bright-field mode to find areas that contain both microtubules and glucagon. Then the specimens were adjusted to the eucentric height and the images were corrected for any astigmatism. The microscope was then switched to STEM mode and dark-field images were collected using a high-angle annular dark-field detector with a camera length of 200 mm, a 2,048 × 2,048 image size, a single-pixel dwell time of 4 μs and a single-frame dwell time of 19.9 s. Only fibrils that are single and not laterally associated were imaged. The intensities of the dark-field STEM images were analyzed using ImageJ. The intensity of a selected area contains contributions from three sources: the proteins of interest, the carbon film of the grid and residual salts from the tubulin buffer. We subtracted the background salt and carbon film intensities from the protein intensities by selecting same-sized rectangles that either contain proteins or are empty. For the microtubules, we drew rectangles with a length of a along the long axis and with a width that encompasses the whole protein and recorded the integrated intensities I std . We also recorded the background intensity I bkg1 in a same-size rectangle in a neighboring area without protein. For glucagon fibrils, rectangles with a length b were drawn over single fibrils and the integrated intensities I fibril were recorded. Intensities in an identical-sized rectangle in a neighboring empty area were recorded as I bkg2 . The MPL (kDa nm . About 290 data points were collected to obtain a statistically significant histogram of the glucagon fibril MPL. 15 N chemical shifts were externally referenced to the 122.00 ppm N-acetylvaline amide peak on the liquid ammonia scale. Most spectra were measured between 268 K and 293 K, as reported by the probe thermocouple. At MAS frequencies of 10.00-15.75 kHz, frictional heating made the sample temperatures 5-10 K warmer than the thermocouple-reported values 53 . The NMR spectra were processed using TopSpin and assigned in Sparky 54 .
Solid
2D
13 C-13 C correlation spectra for 13 C chemical shift assignment and for identifying long-range spatial contacts were measured using dipolarassisted rotational resonance (DARR) 55 and combined R2 n ν -driven (CORD) 56 experiments. For resonance assignment, the DARR and CORD mixing times were 50 and 30 ms, respectively. For water-edited 2D 13 C- 13 C correlation experiments, a 1 H T 2 filter of 1.4-1.7 ms and a 2.25 ms 1 H-1 H spin diffusion period was inserted before 1 H-13 C cross polarization (CP), to transfer the water 1 H magnetization to the peptide protons 28, 32 . To identify inter-residue correlations that constrain the 3D packing of the peptide, we measured three types of 2D 13 C- 13 C correlation spectra. The first type of experiment was proton-driven spin diffusion with mixing times of 0.5 or 1.0 s or CORD mixing for 250 or 500 ms. The second experiment was PAR 23 with a mixing time of 12 ms and 1 H and 13 C radiofrequency fields of 50 and 53 kHz, respectively. The third experiment was CHHC 27 , which began with a 700 μs 1 H-13 C CP and 13 C t 1 evolution, followed by reverse transfer of 13 C magnetization to the directly bonded protons with a 75 μs CP period. This was followed by a 200 μs 
, where n is 2 for Gly and 3 for all other residues.
Backbone (ϕ, ψ) torsion angles were predicted from the measured 13 C and 15 N chemical shifts using the TALOS-N software 60 , which takes 13 Cα, 13 Cβ, 13 CO and 15 N chemical shifts and the amino acid sequence and compares them with a database of protein chemical shifts and torsion angles to determine the secondary structure of the peptide.
Structure calculation. The glucagon fibril structure was calculated using CYANA v.2.1 (ref. 61 ). Structure calculations included two β-sheets of eight monomers each. Monomers were connected using LL5 linkers, which behave as pseudo atoms that do not affect the calculated target function. Conformers I and II alternate in the eight planes perpendicular to the fibril axis. Within each plane, homodimer C 2 symmetry was enforced by the inclusion of torsion angle and relative Cα position symmetry terms in the CYANA target function (weight_ide = 1.0 and weight_sym = 0.1, respectively). To maintain the homodimer C 2 symmetry, we set conformer I-II intermolecular contacts for molecule pairs in which the oddnumbered residues of conformer I are the backbone hydrogen-bond donors and odd-numbered residues of conformer II are the hydrogen-bond acceptor. Structure calculation runs with switched I-II pairs resulted in the same target function and r.m.s.d. as the structure presented herein. To keep interlayer distances consistent with the known cross-β intersheet distances of 4.8 Å (ref. 62 ), the Cα-Cα distances between every other layer were constrained between 9.3 and 9.9 Å; these constraints were given a tenfold greater weight than others. The parallel homomeric interface within each layer comprises even-numbered residues, S2-N28, for conformer I and odd-numbered residues, Q3-M27, for conformer II. This homomeric interface was constrained by an upper distance limit of 10.0 Å between Cα atoms of the same residue, to be consistent with the known intersheet distance of ~10 Å for amyloid fibril steric zippers. Chemical-shift-derived (ϕ, ψ) angles were applied as torsion angle restraints for both conformers I and II; the range was set to be twice the uncertainty given by TALOS-N. For residues S2-T29, which had chemical shifts characteristic of a β-sheet conformation, we imposed hydrogen bonds by setting the O-H N distances to 1.5-1.7 Å and the O-N distances to 2.5-2.7 Å. These constraints were given a tenfold greater weight than others. Upper distance limits for cross peaks observed in various 2D spectra (Supplementary Data Set 2) were set as: 6 Å for 200 μs CHHC spectra and spectra with 13 C spin diffusion mixing times shorter than 100 ms; 7 Å for 250-ms spin diffusion spectra; 8 Å for 500 ms and 1.0 s spin diffusion spectra on an 800 MHz spectrometer and for the 15 ms PERSPIRATION CP spectra 24 ; 8.5 Å for 500 ms spin diffusion spectra on a 600 MHz spectrometer; and 9 Å for the 12 ms PAR spectra. Upper distance limits were increased by 1.5 Å for Trp side chains to account for relayed transfers across the rigid, bulky indole rings. Overall, 700 individual trajectories were run with 150,000 torsion angle steps each. The ten structures with the lowest CYANA target function were included in the final ensemble.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
NMR chemical shifts and distance restraints have been deposited in the Biological Magnetic Resonance Bank (BMRB) under entry 30572. Structural coordinates have been deposited online in the Protein Data Bank under accession code PDB 6NZN. The 2D spectra are available in Supplementary Data Set 1. All distance restraints derived from 13 C-13 C and 15 N-13 C correlation spectra are available in Supplementary Data Set 2. All other data are available from the authors upon reasonable request.
